Terrie Curran
2020
In 2020, Terrie Curran earned a total compensation of $4.6M as President and Chief Executive Officer at Phathom Pharmaceuticals, a 34% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $356,875 |
---|---|
Option Awards | $3,285,608 |
Salary | $498,940 |
Stock Awards | $483,000 |
Other | $10,031 |
Total | $4,634,454 |
Curran received $3.3M in option awards, accounting for 71% of the total pay in 2020.
Curran also received $356.9K in non-equity incentive plan, $498.9K in salary, $483K in stock awards and $10K in other compensation.
Rankings
In 2020, Terrie Curran's compensation ranked 2,416th out of 13,090 executives tracked by ExecPay. In other words, Curran earned more than 81.5% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 2,416 | 82nd |
Manufacturing | 923 | 84th |
Chemicals And Allied Products | 327 | 86th |
Drugs | 278 | 86th |
Pharmaceutical Preparations | 200 | 86th |
Curran's colleagues
We found two more compensation records of executives who worked with Terrie Curran at Phathom Pharmaceuticals in 2020.
News
Phathom Pharmaceuticals CEO Terrie Curran's 2023 pay falls 32% to $3.4M
April 12, 2024
Phathom Pharmaceuticals CEO Terrie Curran's 2022 pay slips 20% to $5M
April 13, 2023
Phathom Pharmaceuticals CEO Terrie Curran's 2020 pay jumps 34% to $4.6M
April 6, 2021
Phathom Pharmaceuticals CEO Terrie Curran receives $3.5M in 2019
April 8, 2020